User login
Aklief Cream Topical Retinoid Approved for Acne Vulgaris
Galderma Laboratories, LP, announces US Food and Drug Administration approval of Aklief (trifarotene) Cream 0.005% for the treatment of acne vulgaris in patients 9 years and older. Trifarotene is a retinoid that selectively targets retinoic acid receptor γ. Aklief Cream treats both facial and truncal acne. Aklief Cream is expected to be available in the United States in November 2019 in a 45-g pump. For more information, visit www.galderma.com.
Altreno Lotion Now Available in a 20-g Tube for Dermatologist Dispensing
Ortho Dermatologics launches a 20-g tube of Altreno (tretinoin) Lotion 0.05% for dermatologists to dispense in their offices. Offering the product in the physician’s office helps ensure that patients will be ready to begin their acne regimen, increasing patient compliance. Altreno Lotion is approved for the treatment of acne vulgaris in patients 9 years and older. It provides efficacy and tolerability in a once-daily dosing regimen. For more information, visit www.altrenohcp.com.
Amzeeq Topical Minocycline Approved for Acne
Foamix Pharmaceuticals Ltd receives US Food and Drug Administration approval of Amzeeq (minocycline) Foam 4% for the treatment of moderate to severe acne vulgaris in patients 9 years and older. Foamix’s proprietary Molecule Stabilizing Technology is used to effectively deliver minocycline—a broad-spectrum antibiotic—in a foam-based vehicle for once-daily application. Amzeeq is expected to be available for prescribing in January 2020. For more information, visit www.foamix.com.
FDA Clears Protego Antimicrobial Wound Dressing
Turn Therapeutics, Inc, receives US Food and Drug Administration clearance of Protego antimicrobial wound dressing for acute and chronic wound management. Protego wound dressings are single-use, sterile, antimicrobial gauze dressings impregnated with Hexagen, a proprietary petrolatum-based wound care emulsion. Protego offers patients the utility of traditional petrolatum-saturated gauze dressings with the added benefit of broad-spectrum antimicrobial protection against bacteria, fungi, and yeasts. For more information, visit www.turntherapeutics.com.
Skin Cancer Foundation Champions for Change Gala Raises More Than $700,000
The Skin Cancer Foundation held its 23rd annual Champions for Change Gala on October 17, 2019. The foundation’s signature fundraising event raised more than $700,000 to support educational campaigns, community programs, and research initiatives. More than 400 guests attended the event at The Plaza Hotel in New York, New York. The event was emceed by comedian Tom Kelly, and President Dr. Deborah S. Sarnoff reflected on the 40th birthday of the foundation, reinforcing the goal “to change behaviors and save lives.” For more information, visit www.
If you would like your product included in Product News, please email a press release to the Editorial Office at cutis@mdedge.com.
Aklief Cream Topical Retinoid Approved for Acne Vulgaris
Galderma Laboratories, LP, announces US Food and Drug Administration approval of Aklief (trifarotene) Cream 0.005% for the treatment of acne vulgaris in patients 9 years and older. Trifarotene is a retinoid that selectively targets retinoic acid receptor γ. Aklief Cream treats both facial and truncal acne. Aklief Cream is expected to be available in the United States in November 2019 in a 45-g pump. For more information, visit www.galderma.com.
Altreno Lotion Now Available in a 20-g Tube for Dermatologist Dispensing
Ortho Dermatologics launches a 20-g tube of Altreno (tretinoin) Lotion 0.05% for dermatologists to dispense in their offices. Offering the product in the physician’s office helps ensure that patients will be ready to begin their acne regimen, increasing patient compliance. Altreno Lotion is approved for the treatment of acne vulgaris in patients 9 years and older. It provides efficacy and tolerability in a once-daily dosing regimen. For more information, visit www.altrenohcp.com.
Amzeeq Topical Minocycline Approved for Acne
Foamix Pharmaceuticals Ltd receives US Food and Drug Administration approval of Amzeeq (minocycline) Foam 4% for the treatment of moderate to severe acne vulgaris in patients 9 years and older. Foamix’s proprietary Molecule Stabilizing Technology is used to effectively deliver minocycline—a broad-spectrum antibiotic—in a foam-based vehicle for once-daily application. Amzeeq is expected to be available for prescribing in January 2020. For more information, visit www.foamix.com.
FDA Clears Protego Antimicrobial Wound Dressing
Turn Therapeutics, Inc, receives US Food and Drug Administration clearance of Protego antimicrobial wound dressing for acute and chronic wound management. Protego wound dressings are single-use, sterile, antimicrobial gauze dressings impregnated with Hexagen, a proprietary petrolatum-based wound care emulsion. Protego offers patients the utility of traditional petrolatum-saturated gauze dressings with the added benefit of broad-spectrum antimicrobial protection against bacteria, fungi, and yeasts. For more information, visit www.turntherapeutics.com.
Skin Cancer Foundation Champions for Change Gala Raises More Than $700,000
The Skin Cancer Foundation held its 23rd annual Champions for Change Gala on October 17, 2019. The foundation’s signature fundraising event raised more than $700,000 to support educational campaigns, community programs, and research initiatives. More than 400 guests attended the event at The Plaza Hotel in New York, New York. The event was emceed by comedian Tom Kelly, and President Dr. Deborah S. Sarnoff reflected on the 40th birthday of the foundation, reinforcing the goal “to change behaviors and save lives.” For more information, visit www.
If you would like your product included in Product News, please email a press release to the Editorial Office at cutis@mdedge.com.
Aklief Cream Topical Retinoid Approved for Acne Vulgaris
Galderma Laboratories, LP, announces US Food and Drug Administration approval of Aklief (trifarotene) Cream 0.005% for the treatment of acne vulgaris in patients 9 years and older. Trifarotene is a retinoid that selectively targets retinoic acid receptor γ. Aklief Cream treats both facial and truncal acne. Aklief Cream is expected to be available in the United States in November 2019 in a 45-g pump. For more information, visit www.galderma.com.
Altreno Lotion Now Available in a 20-g Tube for Dermatologist Dispensing
Ortho Dermatologics launches a 20-g tube of Altreno (tretinoin) Lotion 0.05% for dermatologists to dispense in their offices. Offering the product in the physician’s office helps ensure that patients will be ready to begin their acne regimen, increasing patient compliance. Altreno Lotion is approved for the treatment of acne vulgaris in patients 9 years and older. It provides efficacy and tolerability in a once-daily dosing regimen. For more information, visit www.altrenohcp.com.
Amzeeq Topical Minocycline Approved for Acne
Foamix Pharmaceuticals Ltd receives US Food and Drug Administration approval of Amzeeq (minocycline) Foam 4% for the treatment of moderate to severe acne vulgaris in patients 9 years and older. Foamix’s proprietary Molecule Stabilizing Technology is used to effectively deliver minocycline—a broad-spectrum antibiotic—in a foam-based vehicle for once-daily application. Amzeeq is expected to be available for prescribing in January 2020. For more information, visit www.foamix.com.
FDA Clears Protego Antimicrobial Wound Dressing
Turn Therapeutics, Inc, receives US Food and Drug Administration clearance of Protego antimicrobial wound dressing for acute and chronic wound management. Protego wound dressings are single-use, sterile, antimicrobial gauze dressings impregnated with Hexagen, a proprietary petrolatum-based wound care emulsion. Protego offers patients the utility of traditional petrolatum-saturated gauze dressings with the added benefit of broad-spectrum antimicrobial protection against bacteria, fungi, and yeasts. For more information, visit www.turntherapeutics.com.
Skin Cancer Foundation Champions for Change Gala Raises More Than $700,000
The Skin Cancer Foundation held its 23rd annual Champions for Change Gala on October 17, 2019. The foundation’s signature fundraising event raised more than $700,000 to support educational campaigns, community programs, and research initiatives. More than 400 guests attended the event at The Plaza Hotel in New York, New York. The event was emceed by comedian Tom Kelly, and President Dr. Deborah S. Sarnoff reflected on the 40th birthday of the foundation, reinforcing the goal “to change behaviors and save lives.” For more information, visit www.
If you would like your product included in Product News, please email a press release to the Editorial Office at cutis@mdedge.com.